Anti-EGFR Antibody (D2C7)
Product Specifications
Target
EGFR
Related Pathways
JAK/STAT signaling, Angiogenesis, Tyrosine Kinase/Adaptors
Bioactivity
Anti-EGFR Antibody (D2C7) is a monoclonal antibody targeting EGFR. The recombinant immunotoxin D2C7- (scdsFv) -PE38KDEL, developed from Anti-EGFR Antibody (D2C7), exhibits antitumor activity in glioblastoma models.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog